摘要
目的:探讨胸腔镜下肺癌根治术的安全性及可行性。方法:对比2013年1月至2015年6月,36例胸腔镜下与50例开胸肺癌根治术的手术时间、术中失血量、术后下地时间、术后镇痛时间、术后引流时间、住院天数、术后并发症、医疗费用。结果:二种方法术后并发症无差异(P>0.05)。胸腔镜组术中失血、术后下地、术后镇痛、术后引流、手术时间、住院天除医疗费用外均优于开胸组(P<0.05),术前及术后第1天CRP、IL-6无差异(P>0.05),术后第7天,胸腔镜组CRP与IL-6下降更快,优于开胸组(P<0.05)。结论:胸腔镜治疗肺癌比开胸手术创伤小、愈合快、住院时间短。
Objective：To investigate the safety and efficacy of VATS for resectable non - small cell lung cancer （NSCLC）. Methods ： The clinical findings of 86 patients with NSCLC including 36 cases underwent VATS and 50 cases underwent thoracotomy were retrospectively analyzed. Results：There was no significant difference between 2 groups in postoperative complications （P 〉 0.05）. But the blood loss during operation, postoperative lower, analgesic time, drainage duration and hospitalization except of medical expenses in VATS group were significantly less than that of thoracotomy group （P 〈 0.05 ）. The levels of the CRP and IL - 6 in the two groups were similar preoperatively and on the 1 st day postoperatively （ P 〉 0.05 ）. After operation one week the levels of the CRP and IL - 6 in VATS group was lower than that of the thoracotomy group （P 〈 0.05 ）. Conclusion：VATS is safe and minimally invasive for NSCLC surgery.
出处
《现代肿瘤医学》
CAS
2016年第10期1555-1557,共3页
Journal of Modern Oncology
关键词
肺癌
VATS
开胸术
lung cancer, VATS, thoracotomy
